Foreword Proactive youngstock health management is critical not only to optimise animal welfare and production efficiency and profitability, but also to minimising the environmental impact of livestock production. The morbidity and mortality rates tolerated by some producers, and at times even accepted by their vets, are often far too high. Whether it is the loss of dairy bull calves, who may have little monetary value but nevertheless contribute to both the carbon footprint and other environmental impacts of a dairy if not utilised for food production, dairy heifers with the additional loss of the best genetics in the herd or a beef suckler calf representing the only product of the cow that year, we need to do all we can to prevent death and disease. Even where calves do not die, managing sick animals is costly in treatment and labour and antibiotic use in these animals to treat, and on some farms still to prevent disease, is very likely to contribute to antimicrobial resistance. The only logical conclusion that one can come to is that if cattle units are to remain viable and produce sustainable milk and meat, we need to redouble efforts to prevent disease. Sometimes we talk of new science, while at other times we find ourselves repeating ‘the same old message’. The need for adequate colostrum management is one such case, the messages may not be new but far too many calves still fail to receive enough maternally derived antibody, making the article in this supplement on colostrum vital reading. Don't assume you, or more importantly your clients, know everything there is to know about colostrum. After ensuring calves have received initial protection via maternal derived antibody from colostrum then we need to ensure they are protected from infections as they grow, particularly respiratory diseases. Despite having had good vaccines for over 20 years, their uptake in the national herd I believe is still suboptimal, far too many calves still receive antimicrobials, and poor growth rates are common due to chronic lung damage. Ellie Button explains well in her article ‘Calf disease: an immunological perspective’ the calf's innate and acquired immunity and describes how an understanding of the calf's developing immunity can be used to enhance disease prevention. Finally, Kat Hart and colleagues discuss communication and promoting behaviour change in ‘How to engage farmers in youngstock care: a clinical forum’, something that in the past we have often forgotten. It's not good enough for vets to understand the science and turn a blind eye to poor on farm practices, or to simply tell clients what to do and walk away expecting them to do as they have been told! We often need to motivate clients towards real lasting change, and to do that we all need to communicate better. Together the three articles in this supplement are a powerful combination, the challenge is to read them and then effect valuable changes on your clients’ farms.
Bovine viral diarrhoea virus (BVDV) is a costly disease and its eradication is the focus of the English voluntary scheme, BVDFree. The process of identifying a farm as negative or not negative is broken down into four stages using ADAM: assess disease risk; define herd status; action plan for BVD control; monitor progress. This process is based on the long-established protocols defined by Cattle Health Certification Standards. The first two stages are discussed in this article with the others following in part 2 of this series. The risk assessment for current infection should focus on incoming animals to the herd, boundary fences and existing vaccination programmes. Suitable testing can then follow with a choice of newborn screening or youngstock cohort surveillance, with optional bulk milk analysis in dairy herds. Farms that show initial evidence of endemic BVDV infection can undertake further testing to discover the source.
Increasing numbers of veterinary practices are running courses on the safe and effective use of veterinary medicines. During the last 5 years, demonstration of medicines competence has become increasingly important as part of the farm assurance process. It is now compulsory for Red Tractor assured beef, sheep and dairy farmers to have undertaken recent and suitable medicines training. The correct use of veterinary medicines provides an essential contribution to many topical issues; including antimicrobial and anthelmintic resistance, animal welfare and consumer safety. This article discusses the requirements and content of a medicines course and then draws on the experience of a panel of veterinary surgeons to explore the various approaches to running a medicines course as a veterinary practice.
Bovine viral diarrhoea virus (BVDV) is a costly disease and its eradication is the focus of the English voluntary scheme, BVDFree. The process of identifying a farm as negative or not negative is broken down into four stages using ADAM: assess disease risk; define herd status; action plan for BVD control; monitor progress. This process is based on the long-established protocols defined by Cattle Health Certification Standards. The latter two stages are discussed in this article with the first two discussed in part 1 of this series. Initial testing will identify the farm as negative or not negative for BVDV. Herds that are not negative will require further testing, which will often take the form of screening for a persistently infected (PI) animal, or ‘PI hunt’, by testing every animal in the herd either directly or indirectly for the presence of virus. Maintaining and monitoring BVDV status will require ongoing testing, tag and test, or check test at the farmer's choice, and continued attention to biosecurity, especially in negative herds that are not vaccinated.
Foreword Farming is under increasing scrutiny on environmental issues (including greenhouse gas emissions, resource use, water and air quality, biodiversity and other impacts), in addition to increasing economic and social pressures. It is increasingly clear that we need to ensure that every animal has a good healthy life, while reducing losses throughout the production system. As cattle vets, we work with cattle at every stage of the production cycle, but on many dairy farms, youngstock are still seen as being of secondary importance compared with the mature herd, suffering significant levels of disease, and sustaining high mortality. This is despite the fact that dairy replacements are, or should be, the group with the highest genetic merit on the farm and are the future of the herd. In contrast to the dairy herd, calves from the suckler herd are the only saleable product of the cow and thus her whole production for the year is lost if the calf should die. Despite this, more could still be done on many farms to improve health and productivity of these calves allowing them to be finished faster with associated environmental benefits. For environmental, economic and social reasons, it is no longer acceptable to cull dairy bull calves, or to ignore high levels of morbidity or mortality. An animal that has a suboptimal growth rate or dies represents a financial loss to the farmer, a welfare concern to the consumer, and an environmental impact that is not compensated for by food (milk or meat) production. If we are to serve our clients to the best of our ability and help make their businesses as sustainable as possible, we need a greater focus on youngstock. This supplement is a good place to start with its focus on Mycoplasma bovis, nematode control and the use of NSAIDs in calf scour.
Gut health is crucial to early life success in calves. By enhancing a calf's own ability to fight disease we can aim to reduce incidence.
October 2022 saw the launch of the new Lantra-approved Cattle Foot Health courses to help vets and foot trimmers teach best foot trimming practice to farmers. The author reflects on what she hopes to gain from teaching the courses and changes in the approach to dairy cattle lameness she has seen during her time as a mobility mentor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.